Causaly
PrivateLast Round
Series B
Jul 13, 2023
Total Funding Raised
$82.8M
Company Overview
Causaly operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series B round in July 2023.
Causaly is a biotechnology company that provides an AI-powered platform for life sciences and pharmaceutical research to accelerate drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, NLP & Conversational AI, Business Intelligence, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Causaly Comparables
Compare Causaly with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BenchSci | 89% | |
| Epistemic AI | 83% | |
| Biorelate | 80% |
For institutional investors. Book with your work email.
Causaly Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 13, 2023 | ||||
| Series A Extension | May 19, 2021 | ||||
| Series A | Nov 19, 2019 | ||||
| Seed | Jul 26, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Causaly Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ICONIQ Growth | Series B |
| Visionaries Club | Series B |
| Marathon Venture Capital | Series A, Series A Extension, Series B, Seed |
| Emerge | Seed |
| European Bank for Reconstruction and Development | Series A, Series A Extension, Series B |
| Index Ventures | Series B, Series A Extension |
| Pentech | Series A Extension, Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 8, 2026
Added L’Oréal Group as a customer.
- Mar 8, 2026
Added Lupin Pharmaceuticals as an enterprise customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 12, 2026
Causaly introduces Causaly Work, an agentic AI platform that helps life sciences scientists plan and complete research, analysis, and reporting from discovery through clinical development, in the United Kingdom on Nov 12th '26.
- integrates_withSep 17, 2026
On Sep 17th '26, Causaly announces an expanded collaboration with Microsoft Corp. that integrates agentic scientific research into Microsoft Corp. Copilot, enabling enterprise life sciences teams to access scientifically grounded research within Microsoft 365 workflows, including the Copilot app and Microsoft Teams.
For institutional investors. Book with your work email.
Causaly Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Causaly's valuation, stock price, and market status.
Is Causaly a public or private company?
Causaly is a private company.
What is the current stock price of Causaly?
Causaly is a private company, so its shares have no public market price. Caplight tracks Causaly's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Causaly worth (valuation)?
Valuation information for Causaly is not publicly available.
Can I buy Causaly stock?
Causaly shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Causaly's last funding round?
Causaly's most recent funding round was Series B on July 13, 2023.
Who are the main investors in Causaly?
Key investors in Causaly include ICONIQ Growth, Marathon Venture Capital, Index Ventures, Pentech, EBRD Venture Capital Investment Programme.
Will Causaly IPO soon?
No public IPO plans have been announced for Causaly.
How can I track Causaly secondary market activity?
Caplight tracks bids, offers, and trades in Causaly's shares on secondary markets.